Free Trial

Prestige Consumer Healthcare (PBH) Earnings Date, Estimates & Call Transcripts

Prestige Consumer Healthcare logo
$82.36 -0.43 (-0.52%)
(As of 11/15/2024 ET)

Prestige Consumer Healthcare Latest Earnings Summary

Upcoming Q3
Earnings Date
Feb. 13Estimated
Actual EPS
(Nov. 7)
$1.09
Consensus EPS
(Nov. 7)
$1.09

Prestige Consumer Healthcare released Q2 2025 earnings on November 7, 2024, reporting an EPS of $1.09, which hit analysts' consensus estimates of $1.09. Quarterly revenue fell .9% year-over-year to $283.79 million, above analyst estimates of $282.09 million. With a trailing EPS of $4.11 and a P/E Ratio of 20.04, Prestige Consumer Healthcare's earnings are expected to grow 6.74% next year, from $4.45 to $4.75 per share.

PBH Upcoming Earnings

Prestige Consumer Healthcare's next earnings date is estimated for Thursday, February 13, 2025, based off prior year's reporting schedules.

Get Prestige Consumer Healthcare Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prestige Consumer Healthcare and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PBH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PBH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Prestige Consumer Healthcare Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244$1.00$1.09$1.04 
Q2 20245$1.06$1.11$1.08 
Q3 20245$1.04$1.13$1.08 
Q4 20245$1.10$1.14$1.13 
FY 202419$4.20$4.47$4.32 
Q1 20253$0.86$0.86$0.86 
Q2 20253$1.08$1.09$1.08 
Q3 20253$1.16$1.21$1.19 
Q4 20252$1.24$1.24$1.24 
FY 202511$4.34$4.40$4.37 
Q1 20261$1.10$1.10$1.10 
Q2 20261$1.18$1.18$1.18 
Q3 20261$1.21$1.21$1.21 
Q4 20261$1.23$1.23$1.23 
FY 20264$4.72$4.72$4.72 
Q1 20271$1.20$1.20$1.20 

Prestige Consumer Healthcare Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/13/2025
(Estimated)
------- 
11/7/2024Q2 2025$1.09$1.09-$1.09$282.09M$283.79M          
8/8/2024Q1 2025$0.86$0.90+$0.04$0.82$260.54M$267.10M    
5/14/2024Q4 2024$1.14$1.02 -$0.12$1.06$287.42M$277.00M      
2/8/2024Q4 2023$1.04$1.06+$0.02$1.06$280.25M$282.74M          
11/2/2023Q2 2024$1.07$1.07-$1.07$285.13M$286.32M
8/3/2023Q2 2023$1.01$1.06+$0.05$1.06$278.79M$279.31M          
5/4/2023Q4 2023$1.04$1.07+$0.03$6.97$280.58M$285.90M      
2/2/2023Q3 2023$1.01$1.04+$0.03$1.04$273.84M$275.50M          

Prestige Consumer Healthcare Earnings - Frequently Asked Questions

Prestige Consumer Healthcare has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates. Learn more on PBH's earnings history.

Prestige Consumer Healthcare updated its FY25 earnings guidance on Thursday, November, 7th. The company provided earnings per share guidance of $4.40 to $4.46 for the period, compared to the consensus estimate of $4.42. The company issued revenue guidance of $1.125 billion to $1.140 billion, compared to the consensus revenue estimate of $1.13 billion.

In the previous quarter, Prestige Consumer Healthcare (NYSE:PBH) reported $1.09 earnings per share (EPS) to hit the analysts' consensus estimate of $1.09. Learn more on analysts' earnings estimate vs. PBH's actual earnings.

The conference call for Prestige Consumer Healthcare's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Prestige Consumer Healthcare's latest earnings report can be read online.
Read Transcript

Prestige Consumer Healthcare's earnings report can be found in their filing with the SEC.
View SEC filing

Prestige Consumer Healthcare (NYSE:PBH) has a recorded annual revenue of $1.13 billion.

Prestige Consumer Healthcare (NYSE:PBH) has a recorded net income of $209.34 million. PBH has generated $4.11 earnings per share over the last four quarters.

Prestige Consumer Healthcare (NYSE:PBH) has a trailing price-to-earnings ratio of 20.04 and a forward price-to-earnings ratio of 18.51. The price/earnings-to-growth ratio is 2.32.

Prestige Consumer Healthcare's earnings are expected to grow from $4.45 per share to $4.75 per share in the next year, which is a 6.74% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:PBH) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners